Drug intelligence / Profile preview

Antioxicaps

Development stage
Unknown
Lead developer
Minskintercaps
Modality
Small Molecules
Administration
Oral
01

Overview

Antioxicaps is a combined antioxidant multivitamin preparation developed and manufactured by the Belarusian pharmaceutical company Minskintercaps. The standard formulation contains a synergistic combination of three essential antioxidants: beta-carotene (provitamin A), alpha-tocopheryl acetate (vitamin E), and ascorbic acid (vitamin C). These components work together to protect cell membranes from lipid peroxidation and neutralize reactive oxygen species, thereby reducing oxidative stress. The product is indicated for the prevention and treatment of hypovitaminosis, increasing resistance to infectious diseases, and as a supportive therapy for various chronic conditions including cardiovascular and gastrointestinal disorders. It is available in soft gelatin capsules and is widely marketed in Belarus and other CIS countries as an over-the-counter (OTC) medication. Variants of the product also exist that include additional minerals such as selenium, zinc, or iodine.

Brand names
AntioxicapsАнтиоксикапс
Other names
Antioxicaps-MIC
02

Targets

Reactive oxygen species and lipid peroxyl radicals

Beyond the preview

Go deeper on Antioxicaps.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antioxicaps.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call